IP Library Assignment 070698/0351
Patent Assignment
Reel/Frame 070698/0351

Release of Security Interest

Recorded: 2025-04-01 Pages: 6
Assignor
Assignee
ACACIA PHARMA LIMITED
50 TICE BLVD, SUITE 315, WOODCLIFF LAKE, NEW JERSEY, 07677
Covered Properties (18)
Therapy of Post-Operative Emesis with Amisulpride
Application: 16/346,563 →
Publication: US 2019/0262310
Use of Amisulpride as an Anti-Emetic
Application: 17/834,000 →
Publication: US 2022/0296570
Therapy of Post-Operative Emesis with Amisulpride
Application: 18/364,796 →
Publication: US 2024/0050403
Rescue Treatment of Post Operative Nausea and Vomiting
Application: 17/746,032 →
Publication: US 2023/0100786
Rescue Treatment of Post Operative Nausea and Vomiting
Application: 18/653,318 →
Publication: US 2024/0285579
Use of Amisulpride as an Anti-Emetic
Application: 18/095,612 →
Publication: US 2023/0144973
Therapy of Post-Operative Nausea and Vomiting
Application: 18/014,545 →
Publication: US 2023/0263770
Combinations of Amisulpride and Another Anti-Emetic for Treating Nausea and Vomiting
Application: 15/565,479 →
Publication: US 2018/0071249
Rescue Treatment of Post Operative Nausea and Vomiting
Application: 16/485,008 →
Publication: US 2020/0038369
Use of Amisulpride as an Anti-Emetic
Patent: 8,686,019 →
Application: 13/559,253 →
Publication: US 2013/0022689
Use of Amisulpride as an Anti-Emetic
Patent: 9,084,765 →
Application: 13/559,168 →
Publication: US 2013/0022688
Use of Amisulpride as an Anti-Emetic
Patent: 9,119,836 →
Application: 14/172,194 →
Publication: US 2014/0147517
Use of Amisulpride as an Anti-Emetic
Application: 16/105,268 →
Publication: US 2018/0353473
Use of Amisulpride as an Anti-Emetic
Application: 15/790,481 →
Publication: US 2018/0042896
Use of Amisulpride as an Anti-Emetic
Patent: 9,889,118 →
Application: 15/374,174 →
Publication: US 2017/0087128
Use of Amisulpride as an Anti-Emetic
Patent: 9,545,426 →
Application: 14/812,148 →
Publication: US 2015/0335616
Use of Bethanechol for Treatment of Xerostomia
Application: 15/091,791 →
Publication: US 2016/0287512
Use of Bethaneciol for Treatment of Xerostomia
Patent: 9,149,454 →
Application: 13/505,668 →
Publication: US 2012/0232137
Related Assignments (24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 31, 2012
From: COOPER, NICOLA; GILBERT, JULIAN CLIVE; GRISTWOOD, ROBERT WILLIAM; WYLLIE, MICHAEL GRANT
To: ACACIA PHARMA LIMITED
Reel/Frame 028293/0506 →
Assignment of Assignor's Interest Oct 15, 2012
From: GILBERT, JULIAN CLIVE; GRISTWOOD, ROBERT WILLIAM; COOPER, NICOLA; FOX, GABRIEL
To: ACACIA PHARMA LIMITED
Reel/Frame 029128/0552 →
Assignment of Assignor's Interest Oct 15, 2012
From: GILBERT, JULIAN CLIVE; GRISTWOOD, ROBERT WILLIAM; COOPER, NICOLA; FOX, GABRIEL
To: ACACIA PHARMA LIMITED
Reel/Frame 029128/0514 →
Assignment of Assignor's Interest Oct 7, 2014
From: GILBERT, JULIAN CLIVE; GRISTWOOD, ROBERT WILLIAM; COOPER, NICOLA; FOX, GABRIEL
To: ACACIA PHARMA LIMITED
Reel/Frame 033903/0790 →
Assignment of Assignor's Interest Aug 5, 2015
From: GILBERT, JULIAN CLIVE; GRISTWOOD, ROBERT WILLIAM; COOPER, NICOLA; FOX, GABRIEL
To: ACACIA PHARMA LIMITED
Reel/Frame 036255/0411 →
Security Agreement Feb 24, 2016
From: ACACIA PHARMA LIMITED
To: SILICON VALLEY BANK
Reel/Frame 037899/0594 →
Assignment of Assignor's Interest Apr 6, 2016
From: COOPER, NICOLA; GILBERT, JULIAN CLIVE; GRISTWOOD, ROBERT WILLIAM; WYLLIE, MICHAEL GRANT
To: ACACIA PHARMA LIMITED
Reel/Frame 038207/0598 →
Assignment of Assignor's Interest Dec 12, 2016
From: GILBERT, JULIAN CLIVE; GRISTWOOD, ROBERT WILLIAM; COOPER, NICOLA; FOX, GABRIEL
To: ACACIA PHARMA LIMITED
Reel/Frame 040712/0095 →
Assignment of Assignor's Interest Oct 24, 2017
From: GILBERT, JULIAN CLIVE; GRISTWOOD, ROBERT WILLIAM; COOPER, NICOLA; FOX, GABRIEL
To: ACACIA PHARMA LIMITED
Reel/Frame 043931/0546 →
Assignment of Assignor's Interest Dec 15, 2017
From: GILBERT, JULIAN CLIVE; GRISTWOOD, ROBERT WILLIAM; FOX, GABRIEL
To: ACACIA PHARMA LIMITED
Reel/Frame 044694/0592 →
Release of Security Interest Jul 5, 2018
From: SILICON VALLEY BANK
To: ACACIA PHARMA LIMITED
Reel/Frame 046273/0930 →
Assignment of Assignor's Interest Aug 21, 2018
From: GILBERT, JULIAN CLIVE; GRISTWOOD, ROBERT WILLIAM; COOPER, NICOLA; FOX, GABRIEL
To: ACACIA PHARMA LIMITED
Reel/Frame 046640/0639 →
Assignment of Assignor's Interest Jun 12, 2019
From: GILBERT, JULIAN CLIVE; GRISTWOOD, ROBERT WILLIAM; FOX, GABRIEL
To: ACACIA PHARMA LIMITED
Reel/Frame 049441/0945 →
Assignment of Assignor's Interest Dec 10, 2019
From: GILBERT, JULIAN CLIVE; GRISTWOOD, ROBERT WILLIAM; FOX, GABRIEL
To: ACACIA PHARMA LTD
Reel/Frame 051229/0769 →
Assignment of Assignor's Interest May 17, 2022
From: GILBERT, JULIAN CLIVE; GRISTWOOD, ROBERT WILLIAM; FOX, GABRIEL
To: ACACIA PHARMA LTD
Reel/Frame 059930/0921 →
Assignment of Assignor's Interest Jun 7, 2022
From: GILBERT, JULIAN CLIVE; GRISTWOOD, ROBERT WILLIAM; COOPER, NICOLA; FOX, GABRIEL
To: ACACIA PHARMA LIMITED
Reel/Frame 060120/0492 →
Assignment of Assignor's Interest Mar 31, 2023
From: GILBERT, JULIAN CLIVE; FOX, GABRIEL; GRISTWOOD, ROBERT WILLIAM
To: ACACIA PHARMA LTD
Reel/Frame 063185/0369 →
Security Interest Apr 28, 2023
From: ACACIA PHARMA LIMITED
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 063476/0631 →
Security Interest Oct 11, 2024
From: ACACIA PHARMA LIMITED
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 068873/0911 →
Assignment of Assignor's Interest Feb 20, 2026
From: GILBERT, JULIAN CLIVE; GRISTWOOD, ROBERT WILLIAM; FOX, GABRIEL
To: ACACIA PHARMA LIMITED
Reel/Frame 073853/0001 →
Assignment of Assignor's Interest Feb 26, 2026
From: GILBERT, JULIAN CLIVE; GRISTWOOD, ROBERT WILLIAM; COOPER, NICOLA; FOX, GABRIEL
To: ACACIA PHARMA LIMITED
Reel/Frame 073910/0323 →
Assignment of Assignor's Interest Mar 3, 2026
From: GILBERT, JULIAN CLIVE; GRISTWOOD, ROBERT WILLIAM; FOX, GABRIEL
To: ACACIA PHARMA LTD
Reel/Frame 073958/0622 →
Assignment of Assignor's Interest Mar 4, 2026
From: ACACIA PHARMA LIMITED; ACACIA PHARMA, INC.; EAGLE PHARMACEUTICALS, INC.
To: LXO IRELAND DESIGNATED ACTIVITY COMPANY; LXO US, INC.
Reel/Frame 073967/0303 →
Security Interest Apr 27, 2026
From: LXO IRELAND DESIGNATED ACTIVITY COMPANY
To: KROLL TRUSTEE SERVICES LIMITED, AS SECURITY AGENT
Reel/Frame 074483/0163 →